NLM Digital Collections

Search

Start Over Subjects Drug and Narcotic Control ✖Remove constraint Subjects: Drug and Narcotic Control Subjects Humans ✖Remove constraint Subjects: Humans

1. Prescription drugs: impacts of misuse and accidental overdose in Mississippi

Publication:
Jackson, Mississippi, : Center for Mississippi Health Policy, September 2013
Subject(s):
Drug Overdose -- epidemiology
Drug Overdose -- prevention & control
Prescription Drug Misuse -- mortality
Prescription Drug Misuse -- prevention & control
Prescription Drug Monitoring Programs -- legislation & jurisprudence
Drug and Narcotic Control
Prescription Drug Misuse -- economics
Prescription Drugs -- poisoning
Humans
Mississippi
United States

2. Prescription drug monitoring programs: evolution and evidence

Author(s):
Weiner, Janet, author
Bao, Yuhua, author
Meisel, Zachary, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, June 2017
Subject(s):
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- therapeutic use
Drug and Narcotic Control
Drug Overdose -- epidemiology
Government Programs
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders
Mandatory Programs
State Government
Humans
United States

3. Memory supplements: clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Dietary Supplements
Drug and Narcotic Control
Government Regulation
Marketing of Health Services
Memory -- drug effects
Memory Disorders -- drug therapy
Advertising as Topic
Commerce
Internet
Humans
United States
United States. Federal Trade Commission.
United States. Food and Drug Administration.

4. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Drug and Narcotic Control
Prescription Drug Diversion -- prevention & control
Prescription Drug Misuse -- prevention & control
Voluntary Programs
Government Programs
Pharmacies
Prescription Drugs
State Government
Humans
United States
United States. Drug Enforcement Administration.

5. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

6. Pain in the nation: the drug, alcohol and suicide crises and the need for a national resilience strategy

Author(s):
Segal, Laura M., author
De Biasi, Anne, author
Mueller, Jennifer May, author
May, Kendra, author
Warren, Molly, author
Publication:
Washington, DC : Trust for America's Health, November 2017
Subject(s):
Alcohol-Related Disorders -- epidemiology
Resilience, Psychological
Substance-Related Disorders -- epidemiology
Suicide -- statistics & numerical data
Adolescent
Adult
Alcohol-Related Disorders -- economics
Alcohol-Related Disorders -- mortality
Alcohol-Related Disorders -- prevention & control
Child
Child Abuse
Child Health Services
Child Welfare
Community Mental Health Services
Continental Population Groups
Cost of Illness
Drug and Narcotic Control
Education, Nonprofessional
Family
Food Assistance
Forecasting
Health Care Costs -- statistics & numerical data
Housing
Illicit Drugs
Infant
Life Expectancy
Mental Disorders
Mental Health Services
Middle Aged
Mortality -- trends
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- mortality
Opioid-Related Disorders -- prevention & control
Pain Management
Parenting
Patient Care Team
Practice Patterns, Physicians'
Pregnancy
Prisoners
Rural Population
School Health Services
State Government
Substance-Related Disorders -- economics
Substance-Related Disorders -- mortality
Substance-Related Disorders -- prevention & control
Suicide -- prevention & control
Urban Population
Humans
United States

7. Buprenorphine: an overview for clinicians

Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States